Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness
- PMID: 30385080
- DOI: 10.1016/j.oftal.2018.08.007
Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness
Comment in
-
Comments on: Superdiluted atropine at 0.01% reduces progression of myopia in children and adolescents. A 5-year study of safety and effectiveness.Arch Soc Esp Oftalmol (Engl Ed). 2019 Mar;94(3):153-154. doi: 10.1016/j.oftal.2018.10.008. Epub 2018 Nov 24. Arch Soc Esp Oftalmol (Engl Ed). 2019. PMID: 30482422 English, Spanish. No abstract available.
Comment on
-
Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness.Arch Soc Esp Oftalmol (Engl Ed). 2018 Apr;93(4):182-185. doi: 10.1016/j.oftal.2017.12.015. Epub 2018 Feb 15. Arch Soc Esp Oftalmol (Engl Ed). 2018. PMID: 29398233 Clinical Trial. English, Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources